Posttransplant lenalidomide can slow down multiple myeloma Oncology Nurse Advisor “The results of this trial will change our treatment of multiple myeloma patients,” predicted Thomas Shea, MD, director of the Bone Marrow and Stem Cell Transplant Program at the University of North Carolina Lineberger Comprehensive Cancer Center in ... |
